Iron deficiency anemia, unspecified. D50.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM D50.9 became effective on October 1, 2018.
Now, talking provider-based coding/billing, if you came to my office as an established patient for an iron infusion only, you would be billed J1756, 96365 and 96366 (if the length of the infusion warrants it). 99211 is incidental to the drug administration code.
Adverse effect of iron and its compounds, initial encounter 2016 2017 2018 2019 2020 2021 Billable/Specific Code T45.4X5A is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM T45.4X5A became effective on October 1, 2020.
Unlike oral iron products which must be absorbed through the GI tract, IV iron products are infused directly into the bloodstream in a form that is readily available to the bone marrow for RBC synthesis, resulting in an earlier correction of iron deficiency and anemia.
ICD-10-CM Diagnosis Code T85.610 Breakdown (mechanical) of cranial or spinal infusion catheter
96374 is the code for the physician to administer the IV.
ICD-10 code T80 for Complications following infusion, transfusion and therapeutic injection is a medical classification as listed by WHO under the range - Injury, poisoning and certain other consequences of external causes .
ICD-10 code D50. 9 for Iron deficiency anemia, unspecified is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
V78. 0 - Screening for iron deficiency anemia | ICD-10-CM.
Intravenous (IV) infusions are billed based upon the CPT®/HCPCS description of the service rendered. A provider may bill for the total time of the infusion using the appropriate add-on codes (i.e. the CPT®/HCPCS for each additional unit of time) if the times are documented.
CPT Definition: 96360: Intravenous Infusion, hydration; initial, 31 minutes to 1 hour. 96361: Intravenous Infusion, hydration; each additional hour (list separately in addition to code for primary procedure)
ICD-10-CM Diagnosis Code D50 D50.
Code D64. 9 is the diagnosis code used for Anemia, Unspecified, it falls under the category of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism. Anemia specifically, is a condition in which the number of red blood cells is below normal.
ICD-10-CM classifies acute blood loss anemia to code D62, Acute posthemorrhagic anemia, and chronic blood loss anemia to code D50. 0, Iron deficiency anemia secondary to blood loss (chronic). An Excludes1 note for “anemia due to chronic blood loss (D50.
E61. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM E61.
From ICD-10: For encounters for routine laboratory/radiology testing in the absence of any signs, symptoms, or associated diagnosis, assign Z01. 89, Encounter for other specified special examinations.
9.
Please Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.
11/2000 - Added sodium ferric gluconate complex in sucrose injection for first line treatment of iron deficiency anemia in patients undergoing chronic hemodialysis who are receiving supplemental erythropoeitin therapy. Effective and implementation dates 12/01/2000. (TN 130) (CR 1322)
This NCD has been or is currently being reviewed under the National Coverage Determination process. The following are existing associations with NCAs, from the National Coverage Analyses database.
Iron is a critical structural component of hemoglobin, a key protein found in normal red blood cells (RBCs) which transport oxygen. Without this important building block, anemic patients experience difficulty in restoring adequate, healthy RBCs that improve hematocrit levels. Iron deficiency is a common condition in end stage renal disease (ESRD) patients undergoing hemodialysis. Clinical management of iron deficiency involves treating patients with iron replacement products while they undergo hemodialysis. The available evidence suggests that the mode of intravenous administration is perhaps the most effective treatment for iron deficiency in hemodialysis patients. Unlike oral iron products, which must be absorbed through the GI tract, IV iron products are infused directly into the bloodstream in a form that is readily available to the bone marrow for RBC synthesis, resulting in an earlier correction of iron deficiency and anemia.
Medicare covers Sodium Ferric Gluconate Complex in Sucrose Injection as a first line treatment of Iron Deficiency Anemia when furnished intravenously to patients undergoing chronic hemodialysis who are receiving supplemental erythropoietin therapy.